Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Current Leases: 2019-2024

Historic Current Leases for Collegium Pharmaceutical (COLL) over the last 6 years, with Dec 2024 value amounting to $1.3 million.

  • Collegium Pharmaceutical's Current Leases rose 7.95% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 7.95%. This contributed to the annual value of $1.3 million for FY2024, which is 28.64% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Current Leases stood at $1.3 million for FY2024, which was up 28.64% from $988,000 recorded in FY2023.
  • Over the past 5 years, Collegium Pharmaceutical's Current Leases peaked at $1.3 million during FY2024, and registered a low of $730,000 during FY2020.
  • Over the past 3 years, Collegium Pharmaceutical's median Current Leases value was $1.1 million (recorded in 2022), while the average stood at $1.1 million.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Current Leases surged by 36.61% in 2022, and later fell by 11.15% in 2023.
  • Collegium Pharmaceutical's Current Leases (Yearly) stood at $730,000 in 2020, then rose by 11.51% to $814,000 in 2021, then spiked by 36.61% to $1.1 million in 2022, then declined by 11.15% to $988,000 in 2023, then climbed by 28.64% to $1.3 million in 2024.